Page 1 | Search Results | Diabetes | American Diabetes Association

1-20 of 26

Sort by

Sort Order Select

Meeting Abstracts

951-P: Intermittently Scanned Continuous Glucose Monitoring (isCGM) for T1DM—Subgroup Analysis from the FLASH-UK Study

LALANTHA LEELARATHNA, CHRIS J. SUTTON, MARK EVANS, SANKALPA NEUPANE, GERRY RAYMAN, SARAH LUMLEY, IAIN C. CRANSTON, PARTH NARENDRAN, KATHARINE BARNARD, VICKY P. TAXIARCHI, MATTHEW BURNS, MAISIE E. CAMM, HOOD THABIT, EMMA G. WILMOT, ON BEHALF OF THE FLASH-UK TRIAL STUDY GROUP

Diabetes 2023;72(Supplement_1):951-P

https://doi.org/10.2337/db23-951-P

Published: 20 June 2023

View articletitled, 951-P: Intermittently Scanned Continuous Glucose Monitoring (isCGM) for T1DM—Subgroup Analysis from the FLASH-UK Study

Meeting Abstracts

633-P: Intermittently Scanned Continuous Glucose Monitoring (isCGM) for T1DM—Psychosocial Outcomes from the FLASH-UK Study

KATHARINE BARNARD, VICKY P. TAXIARCHI, MARK EVANS, SANKALPA NEUPANE, GERRY RAYMAN, SARAH LUMLEY, IAIN C. CRANSTON, PARTH NARENDRAN, CHRIS J. SUTTON, MATTHEW BURNS, HOOD THABIT, EMMA G. WILMOT, LALANTHA LEELARATHNA

Diabetes 2023;72(Supplement_1):633-P

https://doi.org/10.2337/db23-633-P

Published: 20 June 2023

View articletitled, 633-P: Intermittently Scanned Continuous Glucose Monitoring (isCGM) for T1DM—Psychosocial Outcomes from the FLASH-UK Study

Meeting Abstracts

904-P: 12-Month Treatment Satisfaction (TS) and Fear of Hypoglycemia (FoH) Outcomes in the ADAPT Study—A Randomized Controlled Trial Comparing an Advanced Hybrid Closed-Loop System (AHCL) to Multiple Daily Injections (MDI) with Intermittently Scanned CGM (isCGM)

OHAD COHEN, PRATIK CHOUDHARY, MARK EVANS, JOHN SHIN, ROSELINE RE, JAVIER CASTAÑEDA, LINDA H. VORRINK - DE GROOT, ASLI ZEYNEP OZDEMIR SALTIK, SIMONA DE PORTU

Diabetes 2023;72(Supplement_1):904-P

https://doi.org/10.2337/db23-904-P

Published: 20 June 2023

View articletitled, 904-P: 12-Month Treatment Satisfaction (TS) and Fear of Hypoglycemia (FoH) Outcomes in the ADAPT Study—A Randomized Controlled Trial Comparing an Advanced Hybrid Closed-Loop System (AHCL) to Multiple Daily Injections (MDI) with Intermittently Scanned CGM (isCGM)

Meeting Abstracts

923-P: CamAPS FX Hybrid Closed-Loop with Ultra-Rapid Insulin Lispro Increases Time in Range Compared with Standard Insulin Lispro in Adults with Type 1 Diabetes—A Double-Blind, Randomized, Crossover Study

MUNACHISO NWOKOLO, RAMA LAKSHMAN, CHARLOTTE K. BOUGHTON, JULIA WARE, JANET M. ALLEN, MALGORZATA E. WILINSKA, HEBA ALWAN, MARK EVANS, ROMAN HOVORKA

Diabetes 2023;72(Supplement_1):923-P

https://doi.org/10.2337/db23-923-P

Published: 20 June 2023

View articletitled, 923-P: CamAPS FX Hybrid Closed-Loop with Ultra-Rapid Insulin Lispro Increases Time in Range Compared with Standard Insulin Lispro in Adults with Type 1 Diabetes—A Double-Blind, Randomized, Crossover Study

Meeting Abstracts

251-OR: The Impact of Identifying Sleep with a Fitbit on Calculated Rates of Nocturnal Hypoglycemia—The Hypo-Metrics Study

GILBERTE MARTINE-EDITH, PATRICK DIVILLY, NATALIE ZAREMBA, UFFE SOEHOLM, ANDREW KINGSNORTH, ZEINAB MAHMOUDI, MIKEL GOMES, BASTIAAN E. DE GALAN, ULRIK PEDERSEN-BJERGAARD, RORY J. MCCRIMMON, ERIC RENARD, SIMON R. HELLER, MARK EVANS, JULIA K. MADER, STEPHANIE A. AMIEL, PRATIK CHOUDHARY, HYPO-RESOLVE CONSORTIUM

Diabetes 2023;72(Supplement_1):251-OR

https://doi.org/10.2337/db23-251-OR

Published: 20 June 2023

View articletitled, 251-OR: The Impact of Identifying Sleep with a Fitbit on Calculated Rates of Nocturnal Hypoglycemia—The Hypo-Metrics Study

Meeting Abstracts

250-OR: Majority of Sensor Hypoglycemia Is Not Detected by People Living with Diabetes—Hypo-METRICS Study

PATRICK DIVILLY, GILBERTE MARTINE-EDITH, ZEINAB MAHMOUDI, NATALIE ZAREMBA, UFFE SOEHOLM, BASTIAAN E. DE GALAN, ULRIK PEDERSEN-BJERGAARD, RORY J. MCCRIMMON, ERIC RENARD, SIMON R. HELLER, MARK EVANS, JULIA K. MADER, STEPHANIE A. AMIEL, PRATIK CHOUDHARY, HYPO-RESOLVE CONSORTIUM

Diabetes 2023;72(Supplement_1):250-OR

https://doi.org/10.2337/db23-250-OR

Published: 20 June 2023

View articletitled, 250-OR: Majority of Sensor Hypoglycemia Is Not Detected by People Living with Diabetes—Hypo-METRICS Study

Meeting Abstracts

392-P: Optimizing Duration and Threshold of Sensor Glucose for Identifying Symptomatic Hypoglycemia in Insulin-Treated Diabetes—Hypo-METRICS Study

PATRICK DIVILLY, ZEINAB MAHMOUDI, GILBERTE MARTINE-EDITH, DIMITRI BOIROUX, NATALIE ZAREMBA, UFFE SOEHOLM, MIKEL GOMES, ALLAN A. VAAG, BASTIAAN E. DE GALAN, ULRIK PEDERSEN-BJERGAARD, RORY J. MCCRIMMON, JULIA K. MADER, MARK EVANS, STEPHANIE A. AMIEL, PRATIK CHOUDHARY, HYPO-RESOLVE CONSORTIUM

Diabetes 2023;72(Supplement_1):392-P

https://doi.org/10.2337/db23-392-P

Published: 20 June 2023

View articletitled, 392-P: Optimizing Duration and Threshold of Sensor Glucose for Identifying Symptomatic Hypoglycemia in Insulin-Treated Diabetes—Hypo-METRICS Study

Meeting Abstracts

391-P: Individualized Optimization of Duration and Threshold of Sensor Hypoglycemia Improves Identification of Symptomatic Hypoglycemia Episodes—Hypo-METRICS Study

ZEINAB MAHMOUDI, PATRICK DIVILLY, GILBERTE MARTINE-EDITH, DIMITRI BOIROUX, NATALIE ZAREMBA, UFFE SOEHOLM, MIKEL GOMES, ALLAN A. VAAG, JANE SPEIGHT, BASTIAAN E. DE GALAN, ULRIK PEDERSEN-BJERGAARD, RORY J. MCCRIMMON, ERIC RENARD, SIMON R. HELLER, MARK EVANS, JULIA K. MADER, STEPHANIE A. AMIEL, PRATIK CHOUDHARY, HYPO-RESOLVE CONSORTIUM

Diabetes 2023;72(Supplement_1):391-P

https://doi.org/10.2337/db23-391-P

Published: 20 June 2023

View articletitled, 391-P: Individualized Optimization of Duration and Threshold of Sensor Hypoglycemia Improves Identification of Symptomatic Hypoglycemia Episodes—Hypo-METRICS Study

Meeting Abstracts

388-P: The Impact of Routine CGM on Hypoglycemia Rates and Psychological Outcomes in the Hypo-METRICS Study

NATALIE ZAREMBA, PATRICK DIVILLY, GILBERTE MARTINE-EDITH, ZEINAB MAHMOUDI, UFFE SOEHOLM, BASTIAAN E. DE GALAN, ULRIK PEDERSEN-BJERGAARD, RORY J. MCCRIMMON, JULIA K. MADER, MARK EVANS, ERIC RENARD, SIMON R. HELLER, JANE SPEIGHT, STEPHANIE A. AMIEL, PRATIK CHOUDHARY

Diabetes 2023;72(Supplement_1):388-P

https://doi.org/10.2337/db23-388-P

Published: 20 June 2023

View articletitled, 388-P: The Impact of Routine CGM on Hypoglycemia Rates and Psychological Outcomes in the Hypo-METRICS Study

Meeting Abstracts

689-P: Comparing the Rates of Sensor-Detected Hypoglycaemia and Patient-Reported Hypoglycaemia by Awareness of Hypoglycaemia Using Continuous Glucose Monitoring: The Hypo-METRICS Trial

PATRICK DIVILLY, GILBERTE MARTINE-EDITH, ZEINAB MAHMOUDI, NATALIE ZAREMBA, UFFE SOEHOLM, ULRIK PEDERSEN-BJERGAARD, RORY J. MCCRIMMON, BASTIAAN E. DE GALAN, ERIC RENARD, SIMON R. HELLER, MARK EVANS, JULIA K. MADER, STEPHANIE A. AMIEL, PRATIK CHOUDHARY, ALEXANDER SEIBOLD

Diabetes 2022;71(Supplement_1):689-P

https://doi.org/10.2337/db22-689-P

Published: 01 June 2022

View articletitled, 689-P: Comparing the Rates of Sensor-Detected Hypoglycaemia and Patient-Reported Hypoglycaemia by Awareness of Hypoglycaemia Using Continuous Glucose Monitoring: The Hypo-METRICS Trial

Meeting Abstracts

688-P: Comparing Rates of Sensor-Detected Hypoglycaemia and Patient-Reported Hypoglycaemia by Method of Glucose Monitoring: The Hypo-METRICS Trial

PATRICK DIVILLY, GILBERTE MARTINE-EDITH, ZEINAB MAHMOUDI, NATALIE ZAREMBA, UFFE SOEHOLM, BASTIAAN E. DE GALAN, ULRIK PEDERSEN-BJERGAARD, RORY J. MCCRIMMON, ERIC RENARD, SIMON R. HELLER, MARK EVANS, STEPHANIE A. AMIEL, PRATIK CHOUDHARY, ALEXANDER SEIBOLD

Diabetes 2022;71(Supplement_1):688-P

https://doi.org/10.2337/db22-688-P

Published: 01 June 2022

View articletitled, 688-P: Comparing Rates of Sensor-Detected Hypoglycaemia and Patient-Reported Hypoglycaemia by Method of Glucose Monitoring: The Hypo-METRICS Trial

Meeting Abstracts

711-P: User Acceptability of Ecological Momentary Assessment to Report Hypoglycemia over Ten Weeks Using a Novel Smartphone Application in the Hypo-METRICS Study: Hypoglycemia Measurements, Thresholds and Impacts

NATALIE ZAREMBA, GILBERTE MARTINE-EDITH, PATRICK DIVILLY, ZEINAB MAHMOUDI, UFFE SOEHOLM, MELANIE M. BROADLEY, FRANS POUWER, BASTIAAN E. DE GALAN, ULRIK PEDERSEN-BJERGAARD, RORY J. MCCRIMMON, ERIC RENARD, SIMON R. HELLER, MARK EVANS, JULIA K. MADER, ALEXANDER SEIBOLD, STEPHANIE A. AMIEL, PRATIK CHOUDHARY, HYPO-RESOLVE CONSORTIUM

Diabetes 2022;71(Supplement_1):711-P

https://doi.org/10.2337/db22-711-P

Published: 01 June 2022

View articletitled, 711-P: User Acceptability of Ecological Momentary Assessment to Report Hypoglycemia over Ten Weeks Using a Novel Smartphone Application in the Hypo-METRICS Study: Hypoglycemia Measurements, Thresholds and Impacts

Meeting Abstracts

233-OR: Impact of Nocturnal Hypoglycemia on Daily Sleep Quality, Mood, and Alertness among Adults with Type 1 Diabetes: The Hypo-METRICS (Hypoglycaemia Measurement, Thresholds, and Impacts) Study

Diabetes 2022;71(Supplement_1):233-OR

https://doi.org/10.2337/db22-233-OR

Published: 01 June 2022

View articletitled, 233-OR: Impact of Nocturnal Hypoglycemia on Daily Sleep Quality, Mood, and Alertness among Adults with Type 1 Diabetes: The Hypo-METRICS (Hypoglycaemia Measurement, Thresholds, and Impacts) Study

Meeting Abstracts

770-P: Treatment Satisfaction and Fear of Hypoglycemia in the ADAPT Study: A Six-Month, Randomized Controlled Trial Comparing an Advanced Hybrid Closed-Loop System to Multiple Daily Injections (MDI) with Intermittently Scanned CGM (isCGM)

SIMONA DE PORTU, PRATIK CHOUDHARY, JENS KROEGER, CHARLES THIVOLET, MARK EVANS, ROSELINE RÉ, LINDA VORRINK DE GROOT, JOHN SHIN, AKLILU HABTEAB GHEBRETINSAE, JAVIER CASTAÑEDA, OHAD COHEN, ADAPT STUDY GROUP

Diabetes 2022;71(Supplement_1):770-P

https://doi.org/10.2337/db22-770-P

Published: 01 June 2022

View articletitled, 770-P: Treatment Satisfaction and Fear of Hypoglycemia in the ADAPT Study: A Six-Month, Randomized Controlled Trial Comparing an Advanced Hybrid Closed-Loop System to Multiple Daily Injections (MDI) with Intermittently Scanned CGM (isCGM)

Meeting Abstracts

1311-P: Glucokinase in AGRP Neurons Is Required for Normal Insulin Secretion and Action in Female Mice

MASA JOSIPOVIC, EMILY O. STARICOFF, CHRISTINE H. RICHES, LAURA SHEPPARD, MARK EVANS

Diabetes 2022;71(Supplement_1):1311-P

https://doi.org/10.2337/db22-1311-P

Published: 01 June 2022

View articletitled, 1311-P: Glucokinase in AGRP Neurons Is Required for Normal Insulin Secretion and Action in Female Mice

Meeting Abstracts

105-OR: An Exploratory Phase 2a, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Cotadutide on Energy Balance in Overweight and Obese Subjects with Type 2 Diabetes Mellitus

RAJNA GOLUBIC, JANE KENNET, VICTORIA E. PARKER, DARREN ROBERTSON, DAN LUO, LARS HANSEN, LUTZ JERMUTUS, PHILIP AMBERY, ADRIAN PARK, MARK EVANS

Diabetes 2021;70(Supplement_1):105-OR

https://doi.org/10.2337/db21-105-OR

Published: 01 June 2021

View articletitled, 105-OR: An Exploratory Phase 2a, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Cotadutide on Energy Balance in Overweight and Obese Subjects with Type 2 Diabetes Mellitus

Meeting Abstracts

115-LB: Optimal Sampling Duration of Hybrid Closed-Loop Therapy to Determine Long-Term Glycemic Control in Adults with Type 1 Diabetes

LALANTHA LEELARATHNA, HOOD THABIT, MALGORZATA E. WILINSKA, LIA BALLY, JULIA K. MADER, SABINE ARNOLDS, CARSTEN BENESCH, THOMAS R. PIEBER, VIRAL N. SHAH, ANDERS L. CARLSON, RICHARD M. BERGENSTAL, MARK EVANS, ROMAN HOVORKA, ON BEHALF OF AP@HOME AND APCAM11 CONSORTIA

Diabetes 2019;68(Supplement_1):115-LB

https://doi.org/10.2337/db19-115-LB

Published: 01 June 2019

View articletitled, 115-LB: Optimal Sampling Duration of Hybrid Closed-Loop Therapy to Determine Long-Term Glycemic Control in Adults with Type 1 Diabetes

Meeting Abstracts

1047-P: Can Closed-Loop Overcome High Day-to-Day Variability of Insulin Needs in Inpatients on General Wards?

CHARLOTTE K. BOUGHTON, LIA BALLY, HOOD THABIT, SARA HARTNELL, DAVID HERZIG, ANDREAS VOGT, EVELINE ANDEREGGEN, YUE RUAN, MALGORZATA E. WILINSKA, MARK EVANS, MARIA M. WERTLI, ANTHONY P. COLL, CHRISTOPH STETTLER, ROMAN HOVORKA

Diabetes 2019;68(Supplement_1):1047-P

https://doi.org/10.2337/db19-1047-P

Published: 01 June 2019

View articletitled, 1047-P: Can Closed-Loop Overcome High Day-to-Day Variability of Insulin Needs in Inpatients on General Wards?

Meeting Abstracts

1046-P: Day-to-Day Variability of Insulin Requirements in Inpatients on General Wards

Diabetes 2019;68(Supplement_1):1046-P

https://doi.org/10.2337/db19-1046-P

Published: 01 June 2019

View articletitled, 1046-P: Day-to-Day Variability of Insulin Requirements in Inpatients on General Wards

Meeting Abstracts

1039-P: Hybrid Closed-Loop in Adults with Type 1 Diabetes: Impact of Baseline A1c on Glucose Outcomes and Insulin Delivery

LALANTHA LEELARATHNA, HOOD THABIT, MALGORZATA E. WILINSKA, LIA BALLY, JULIA K. MADER, SABINE ARNOLDS, THOMAS R. PIEBER, VIRAL N. SHAH, ANDERS CARLSON, RICHARD M. BERGENSTAL, MARK EVANS, ROMAN HOVORKA

Diabetes 2019;68(Supplement_1):1039-P

https://doi.org/10.2337/db19-1039-P

Published: 01 June 2019

View articletitled, 1039-P: Hybrid Closed-Loop in Adults with Type 1 Diabetes: Impact of Baseline A1c on Glucose Outcomes and Insulin Delivery

Update search

NARROW

Format

Journal

Article Type

Topics

Issue Section

Date

Availability

951-P: Intermittently Scanned Continuous Glucose Monitoring (isCGM) for T1DM—Subgroup Analysis from the FLASH-UK Study

633-P: Intermittently Scanned Continuous Glucose Monitoring (isCGM) for T1DM—Psychosocial Outcomes from the FLASH-UK Study

904-P: 12-Month Treatment Satisfaction (TS) and Fear of Hypoglycemia (FoH) Outcomes in the ADAPT Study—A Randomized Controlled Trial Comparing an Advanced Hybrid Closed-Loop System (AHCL) to Multiple Daily Injections (MDI) with Intermittently Scanned CGM (isCGM)

923-P: CamAPS FX Hybrid Closed-Loop with Ultra-Rapid Insulin Lispro Increases Time in Range Compared with Standard Insulin Lispro in Adults with Type 1 Diabetes—A Double-Blind, Randomized, Crossover Study

251-OR: The Impact of Identifying Sleep with a Fitbit on Calculated Rates of Nocturnal Hypoglycemia—The Hypo-Metrics Study

250-OR: Majority of Sensor Hypoglycemia Is Not Detected by People Living with Diabetes—Hypo-METRICS Study

392-P: Optimizing Duration and Threshold of Sensor Glucose for Identifying Symptomatic Hypoglycemia in Insulin-Treated Diabetes—Hypo-METRICS Study

391-P: Individualized Optimization of Duration and Threshold of Sensor Hypoglycemia Improves Identification of Symptomatic Hypoglycemia Episodes—Hypo-METRICS Study

388-P: The Impact of Routine CGM on Hypoglycemia Rates and Psychological Outcomes in the Hypo-METRICS Study

689-P: Comparing the Rates of Sensor-Detected Hypoglycaemia and Patient-Reported Hypoglycaemia by Awareness of Hypoglycaemia Using Continuous Glucose Monitoring: The Hypo-METRICS Trial

688-P: Comparing Rates of Sensor-Detected Hypoglycaemia and Patient-Reported Hypoglycaemia by Method of Glucose Monitoring: The Hypo-METRICS Trial

711-P: User Acceptability of Ecological Momentary Assessment to Report Hypoglycemia over Ten Weeks Using a Novel Smartphone Application in the Hypo-METRICS Study: Hypoglycemia Measurements, Thresholds and Impacts

233-OR: Impact of Nocturnal Hypoglycemia on Daily Sleep Quality, Mood, and Alertness among Adults with Type 1 Diabetes: The Hypo-METRICS (Hypoglycaemia Measurement, Thresholds, and Impacts) Study

770-P: Treatment Satisfaction and Fear of Hypoglycemia in the ADAPT Study: A Six-Month, Randomized Controlled Trial Comparing an Advanced Hybrid Closed-Loop System to Multiple Daily Injections (MDI) with Intermittently Scanned CGM (isCGM)

1311-P: Glucokinase in AGRP Neurons Is Required for Normal Insulin Secretion and Action in Female Mice

105-OR: An Exploratory Phase 2a, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Cotadutide on Energy Balance in Overweight and Obese Subjects with Type 2 Diabetes Mellitus

115-LB: Optimal Sampling Duration of Hybrid Closed-Loop Therapy to Determine Long-Term Glycemic Control in Adults with Type 1 Diabetes

1047-P: Can Closed-Loop Overcome High Day-to-Day Variability of Insulin Needs in Inpatients on General Wards?

1046-P: Day-to-Day Variability of Insulin Requirements in Inpatients on General Wards

1039-P: Hybrid Closed-Loop in Adults with Type 1 Diabetes: Impact of Baseline A1c on Glucose Outcomes and Insulin Delivery

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

Update search

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

This Feature Is Available To Subscribers Only